<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Hangzhou Tigermed Consulting — News on 6ix</title>
    <link>https://6ix.com/company/hangzhou-tigermed-consulting</link>
    <description>Latest news and press releases for Hangzhou Tigermed Consulting on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 30 Mar 2026 12:56:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/hangzhou-tigermed-consulting" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68365d5678dffbe2df15a5f8.webp</url>
      <title>Hangzhou Tigermed Consulting</title>
      <link>https://6ix.com/company/hangzhou-tigermed-consulting</link>
    </image>
    <item>
      <title>Tigermed Announces 2025 Annual Results</title>
      <link>https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-announces-2025-annual-results</link>
      <guid isPermaLink="true">https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-announces-2025-annual-results</guid>
      <pubDate>Mon, 30 Mar 2026 12:56:00 GMT</pubDate>
      <description>Hangzhou Tigermed Consulting Co., Ltd. (&quot;Tigermed&quot; or the &quot;company&quot;) (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2025 (the &quot;Reporting Period&quot;).</description>
    </item>
    <item>
      <title>Tigermed Selected as &quot;2025 Forbes China Go-International Flagship Brands&quot; Top 30</title>
      <link>https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-selected-2025-forbes-china-100800274</link>
      <guid isPermaLink="true">https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-selected-2025-forbes-china-100800274</guid>
      <pubDate>Thu, 06 Nov 2025 10:08:00 GMT</pubDate>
      <description>Tigermed has been selected as one of the Top 30 companies on the &quot;2025 Forbes China Go-International Flagship Brands&quot; list, Forbes China announced Tuesday.</description>
    </item>
    <item>
      <title>Tigermed Receives MSCI ESG AAA Rating</title>
      <link>https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-receives-msci-esg-aaa-031500133</link>
      <guid isPermaLink="true">https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-receives-msci-esg-aaa-031500133</guid>
      <pubDate>Tue, 19 Aug 2025 03:15:00 GMT</pubDate>
      <description>Tigermed is proud to announce that it has been awarded an MSCI Environmental, Social, and Governance (ESG) Rating of AAA, the highest rating in the industry. This recognition underscores our commitment to excellence in ESG practices, positioning us as a leader in sustainable business performance.</description>
    </item>
    <item>
      <title>Tigermed Completes Acquisition of Japanese CRO Micron</title>
      <link>https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-completes-acquisition-japanese-cro-053700466</link>
      <guid isPermaLink="true">https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-completes-acquisition-japanese-cro-053700466</guid>
      <pubDate>Tue, 29 Jul 2025 05:37:00 GMT</pubDate>
      <description>Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Micron,Inc.</description>
    </item>
    <item>
      <title>Tigermed Reports Full Year 2024 Results</title>
      <link>https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-reports-full-2024-results-104800407</link>
      <guid isPermaLink="true">https://6ix.com/company/hangzhou-tigermed-consulting/news/tigermed-reports-full-2024-results-104800407</guid>
      <pubDate>Thu, 27 Mar 2025 10:48:00 GMT</pubDate>
      <description>Hangzhou Tigermed Consulting Co., Ltd. (&quot;Tigermed&quot; or the &quot;company&quot;) (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2024 (the &quot;Reporting Period&quot;).</description>
    </item>
  </channel>
</rss>